249 related articles for article (PubMed ID: 28424421)
21. Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells.
Jeong HJ; Lam Y; de Lumen BO
J Agric Food Chem; 2002 Oct; 50(21):5903-8. PubMed ID: 12358457
[TBL] [Abstract][Full Text] [Related]
22. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
23. Lunasin is a redox sensitive intrinsically disordered peptide with two transiently populated α-helical regions.
Aleksis R; Jaudzems K; Muceniece R; Liepinsh E
Peptides; 2016 Nov; 85():56-62. PubMed ID: 27639324
[TBL] [Abstract][Full Text] [Related]
24. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
[TBL] [Abstract][Full Text] [Related]
25. Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb).
Jeong JB; Jeong HJ; Park JH; Lee SH; Lee JR; Lee HK; Chung GY; Choi JD; de Lumen BO
J Agric Food Chem; 2007 Dec; 55(26):10707-13. PubMed ID: 18038993
[TBL] [Abstract][Full Text] [Related]
26. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling.
Deng Z; Zeng Q; Chai J; Zhang B; Zheng W; Xu X; Wu J
Curr Cancer Drug Targets; 2020; 20(4):306-315. PubMed ID: 31893992
[TBL] [Abstract][Full Text] [Related]
27. Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines.
Lam Y; Galvez A; de Lumen BO
Nutr Cancer; 2003; 47(1):88-94. PubMed ID: 14769542
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the bioactive lunasin peptide in soybean and evaluation of its anti-inflammatory and anti-cancer activities in vitro.
Hao Y; Fan X; Guo H; Yao Y; Ren G; Lv X; Yang X
J Biosci Bioeng; 2020 Apr; 129(4):395-404. PubMed ID: 31784283
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of thrombospondin (THBS1) in tumorigenic and nontumorigenic prostate epithelial cells in response to a chromatin-binding soy peptide.
Galvez AF; Huang L; Magbanua MM; Dawson K; Rodriguez RL
Nutr Cancer; 2011; 63(4):623-36. PubMed ID: 21526452
[TBL] [Abstract][Full Text] [Related]
30. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI
Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446
[TBL] [Abstract][Full Text] [Related]
31. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
32. Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial.
Bedlack RS; Wicks P; Vaughan T; Opie A; Blum R; Dios A; Sadri-Vakili G
Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):285-293. PubMed ID: 30663902
[No Abstract] [Full Text] [Related]
33. Understanding Lunasin's biology and potential as a cancer therapeutic by utilizing Drosophila genetics.
Jones G; Srivastava A
Exp Biol Med (Maywood); 2014 May; 239(5):519-28. PubMed ID: 24625440
[TBL] [Abstract][Full Text] [Related]
34. Conformation-dependent binding of a Tetrastatin peptide to α
Lambert E; Fuselier E; Ramont L; Brassart B; Dukic S; Oudart JB; Dupont-Deshorgue A; Sellier C; Machado C; Dauchez M; Monboisse JC; Maquart FX; Baud S; Brassart-Pasco S
Sci Rep; 2018 Jun; 8(1):9837. PubMed ID: 29959360
[TBL] [Abstract][Full Text] [Related]
35. Scalable purification and characterization of the anticancer lunasin peptide from soybean.
Seber LE; Barnett BW; McConnell EJ; Hume SD; Cai J; Boles K; Davis KR
PLoS One; 2012; 7(4):e35409. PubMed ID: 22514740
[TBL] [Abstract][Full Text] [Related]
36. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
Touil Y; Zuliani T; Wolowczuk I; Kuranda K; Prochazkova J; Andrieux J; Le Roy H; Mortier L; Vandomme J; Jouy N; Masselot B; Ségard P; Quesnel B; Formstecher P; Polakowska R
Stem Cells; 2013 Apr; 31(4):641-51. PubMed ID: 23355370
[TBL] [Abstract][Full Text] [Related]
37. Lunasin and Its Epigenetic Impact in Cancer Chemoprevention.
Kaufman-Szymczyk A; Kaczmarek W; Fabianowska-Majewska K; Lubecka-Gajewska K
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298139
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory Effects of Peptide Lunasin in Colorectal Cancer HCT-116 Cells and Their Tumorsphere-Derived Subpopulation.
Fernández-Tomé S; Xu F; Han Y; Hernández-Ledesma B; Xiao H
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947688
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris.
Soszka T; Knudsen KA; Beviglia L; Rossi C; Poggi A; Niewiarowski S
Exp Cell Res; 1991 Sep; 196(1):6-12. PubMed ID: 1879472
[TBL] [Abstract][Full Text] [Related]
40. Amaranth lunasin-like peptide internalizes into the cell nucleus and inhibits chemical carcinogen-induced transformation of NIH-3T3 cells.
Maldonado-Cervantes E; Jeong HJ; León-Galván F; Barrera-Pacheco A; De León-Rodríguez A; González de Mejia E; de Lumen BO; Barba de la Rosa AP
Peptides; 2010 Sep; 31(9):1635-42. PubMed ID: 20599579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
